Erika Finanger

2.3k citations

26 papers · 682 indexed · h-index 12

Co-authors: Krista Vandenborne Glenn A. Walter William D. Rooney Sean C. Forbes Barry S. Russman Gihan Tennekoon H. Lee Sweeney Rebecca J. Willcocks
Topics: Muscle Physiology and Disorders (20 papers)Muscle activation and electromyography studies (5 papers)Genetic Neurodegenerative Diseases (5 papers)
Cited by: Genetics Molecular Biology Cellular and Molecular Neuroscience
Journals: PLoS ONE Neurology Annals of Neurology
Partner nations: United States Italy Canada

In The Last Decade

Erika Finanger

25 papers receiving 678 citations

Peers

Countries citing papers authored by Erika Finanger

Since Specialization

Citations

This map shows the geographic impact of Erika Finanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Finanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Finanger more than expected).

Fields of papers citing papers by Erika Finanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Finanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Finanger. The network helps show where Erika Finanger may publish in the future.

Co-authorship network of co-authors of Erika Finanger

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Finanger. A scholar is included among the top collaborators of Erika Finanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Finanger. Erika Finanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy 2023 ·Annals of Clinical and Translational Neurology ·Rebecca J. Willcocks,(unknown),Michael J. Daniels,Sean C. Forbes,William Triplett,John F. Brandsema,Erika Finanger,William D. Rooney,Sarah Kim,(unknown),Donovan J. Lott,Claudia Senesac,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	3
2	Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort 2020 ·Radiology ·Sean C. Forbes,(unknown),Rebecca J. Willcocks,William Triplett,William D. Rooney,(unknown),(unknown),Dah-Jyuu Wang,Donovan J. Lott,Claudia Senesac,Ann T. Harrington,Erika Finanger,Gihan Tennekoon,John F. Brandsema,Michael J. Daniels,H. Lee Sweeney,Glenn A. Walter,Krista Vandenborne	27
3	MR biomarkers predict clinical function in Duchenne muscular dystrophy 2020 ·Neurology ·(unknown),Rebecca J. Willcocks,William Triplett,Sean C. Forbes,Michael J. Daniels,Saptarshi Chakraborty,Donovan J. Lott,Claudia Senesac,Erika Finanger,Ann T. Harrington,Gihan Tennekoon,(unknown),Dah-Jyuu Wang,H. Lee Sweeney,William D. Rooney,Glenn A. Walter,Krista Vandenborne	59
4	Walking activity in a large cohort of boys with Duchenne muscular dystrophy 2020 ·Muscle & Nerve ·Donovan J. Lott,Tanja Taivassalo,Claudia Senesac,Rebecca J. Willcocks,(unknown),(unknown),(unknown),Catherine A. Powers,Erika Finanger,William D. Rooney,Gihan Tennekoon,Krista Vandenborne	15
5	Edasalonexent, an NF-kB Inhibitor, Slows Longer-Term Disease Progression on Multiple Functional and MRI Assessments Compared to Control Period in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy (S51.006) 2019 ·Neurology ·Richard S. Finkel,Krista Vandenborne,H. Lee Sweeney,Erika Finanger,Gihan Tennekoon,Perry B. Shieh,(unknown),Glenn A. Walter,William D. Rooney,Sean C. Forbes,William Triplett,Sabrina W. Yum,Maria Mancini,James E. MacDougall,(unknown),Pradeep Bista,Andrew J. Nichols,Joanne M. Donovan	2
6	O.42Treatment of young boys with Duchenne muscular dystrophy with the NF-κB inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures 2019 ·Neuromuscular Disorders ·Richard S. Finkel,Krista Vandenborne,H. Lee Sweeney,Erika Finanger,G. Tennekoon,Perry B. Shieh,Rebecca J. Willcocks,Glenn A. Walter,William D. Rooney,Sean C. Forbes,William Triplett,Sabrina W. Yum,Maria Mancini,James E. MacDougall,(unknown),Pradeep Bista,A. Nichols,J. Donovan	2
7	Longitudinal ophthalmic findings in a child with Helsmoortel-Van der Aa Syndrome 2018 ·American Journal of Ophthalmology Case Reports ·Michael J. Gale,(unknown),(unknown),(unknown),(unknown),Jenny L. Wilson,David M. Koeller,Erika Finanger,Peter A. Blasco,Pei-Wen Chiang,Daniel J. Karr,Paul Yang	6
8	Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy 2018 ·PLoS ONE ·(unknown),Rebecca J. Willcocks,Erika Finanger,Michael J. Daniels,William Triplett,William D. Rooney,Donovan J. Lott,Sean C. Forbes,Dah-Jyuu Wang,Claudia Senesac,Ann T. Harrington,Richard S. Finkel,Barry S. Russman,Barry J. Byrne,Gihan Tennekoon,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	51
9	Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy 2018 ·Journal of Neuromuscular Diseases ·Erika Finanger,Krista Vandenborne,Richard S. Finkel,H. Lee Sweeney,Gihan Tennekoon,Sabrina W. Yum,Maria Mancini,Pradeep Bista,Andrew J. Nichols,Hanlan Liu,(unknown),Joanne M. Donovan	30
10	MoveDMD®: Positive Effects of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy in Phase 2 Study with an Open-Label Extension (S29.006) 2018 ·Neurology ·Richard S. Finkel,Krista Vandenborne,H. Lee Sweeney,Erika Finanger,Gihan Tennekoon,Perry B. Shieh,Rebecca J. Willcocks,Sean C. Forbes,William Triplett,Sabrina W. Yum,Maria Mancini,(unknown),Joanne M. Donovan	1
11	Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history 2018 ·Muscle & Nerve ·(unknown),Rebecca J. Willcocks,Donovan J. Lott,Ann T. Harrington,Claudia Senesac,(unknown),Michael J. Daniels,Dandan Xu,Gihan Tennekoon,Erika Finanger,Barry S. Russman,Richard S. Finkel,William Triplett,Barry J. Byrne,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	46
12	Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210) 2017 ·Neurology ·Joanne M. Donovan,Krista Vandenborne,(unknown),Gihan Tennekoon,Erika Finanger,Sabrina W. Yum,Perry B. Shieh,Maria Mancini,Pradeep Bista,Andrew J. Nichols,Richard S. Finkel	1
13	Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort 2016 ·Annals of Neurology ·Rebecca J. Willcocks,William D. Rooney,William Triplett,Sean C. Forbes,Donovan J. Lott,Claudia Senesac,Michael J. Daniels,(unknown),Ann T. Harrington,Gihan Tennekoon,Barry S. Russman,Erika Finanger,Barry J. Byrne,Richard S. Finkel,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	120
14	CAT-1004, an oral agent targeting NF-kB: MoveDMD trial results in Duchenne muscular dystrophy (DMD) 2016 ·Neuromuscular Disorders ·Erika Finanger,Krista Vandenborne,Richard S. Finkel,H. Lee Sweeney,G. Tennekoon,Sabrina W. Yum,Maria Mancini,(unknown),Pradeep Bista,A. Nichols,J. Donovan	1
15	Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study 2014 ·PLoS ONE ·Sean C. Forbes,Rebecca J. Willcocks,William Triplett,William D. Rooney,Donovan J. Lott,Dah-Jyuu Wang,Jim Pollaro,Claudia Senesac,Michael J. Daniels,Richard S. Finkel,Barry S. Russman,Barry J. Byrne,Erika Finanger,Gihan Tennekoon,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	87
16	Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS 2014 ·Neurology ·Ishu Arpan,Rebecca J. Willcocks,Sean C. Forbes,Richard S. Finkel,Donovan J. Lott,William D. Rooney,William Triplett,Claudia Senesac,Michael J. Daniels,Barry J. Byrne,Erika Finanger,Barry S. Russman,Dah-Jyuu Wang,Gihan Tennekoon,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	116
17	A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease 2013 ·Molecular Genetics and Metabolism ·Priya S. Kishnani,Mark A. Tarnopolsky,(unknown),Mark Roberts,Barry J. Byrne,Özlem Göker-Alpan,(unknown),Muhammad Pervaiz,Majed Dasouki,(unknown),Erika Finanger,Franklin K. Johnson,Pol Boudes	5
18	P.13.5 Magnetic resonance imaging and spectroscopy detect changes with age, corticosteroid treatment, and functional progression in DMD 2013 ·Neuromuscular Disorders ·Rebecca J. Willcocks,Sean C. Forbes,Erika Finanger,Barry S. Russman,Donovan J. Lott,Claudia Senesac,William Triplett,Ishu Arpan,Michael J. Daniels,Barry J. Byrne,Richard S. Finkel,G. Tennekoon,William D. Rooney,Glenn A. Walter,H. Lee Sweeney,Krista Vandenborne	4
19	Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular Dystrophy 2011 ·Physical Medicine and Rehabilitation Clinics of North America ·Erika Finanger,Barry S. Russman,Sean C. Forbes,William D. Rooney,Glenn A. Walter,Krista Vandenborne	60
20	Lack of association between temporal lobe epilepsy and a novel polymorphism in the alpha 2 subunit gene (ATP1A2) of the sodium potassium transporting ATPase 2000 ·American Journal of Medical Genetics ·Russell J. Buono,Thomas N. Ferraro,Matthew J. O’Connor,Michael R. Sperling,(unknown),Erika Finanger,Falk W. Lohoff,(unknown),Wade H. Berrettini	20

About Erika Finanger

Erika Finanger is a scholar working on Genetics, Molecular Biology and Cellular and Molecular Neuroscience, having authored 26 papers that have together received 682 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (20 papers), Muscle activation and electromyography studies (5 papers) and Genetic Neurodegenerative Diseases (5 papers). The work is most often cited by research in Genetics (94 citations), Molecular Biology (568 citations) and Cellular and Molecular Neuroscience (150 citations). Erika Finanger has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Krista Vandenborne, Glenn A. Walter, William D. Rooney, Sean C. Forbes, Barry S. Russman, Gihan Tennekoon, H. Lee Sweeney, Rebecca J. Willcocks, Claudia Senesac and Donovan J. Lott. Their work appears in journals such as PLoS ONE, Neurology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact